More women should be assessed for BRCA mutations, new recommendations say:

The updated recommendation notes that for women who are recommended for screening for BRCA1 or BRCA2 mutations, that genetic risk assessment and BRCA mutation testing is a multi-step process, which typically begins with assessing risk at a visit with a primary care doctor.

The updated USPSTF recommendation statement clarifies that primary care clinicians should assess women with a personal or family history of breast, ovarian, tubal or peritoneal cancer for possible BRCA1 or BRCA2 mutations, said Dr. Banu Arun, professor of breast medical oncology and co-medical director of the Clinical Cancer Genetics Program at MD Anderson Cancer Center in Houston, who was not involved in the new recommendations.

Leave a Reply

Close Menu